1. Inhibitory Effect of a Novel Thiazolidinedione Derivative on Hepatitis B Virus Entry. Tanaka, T., K. Okuyama-Dobashi, R. Motohashi, H. Yokoe, K. Takahashi, P. Wiriyasermkul, H. Kasai, A. Yamashita, S. Maekawa, N. Enomoto, A. Ryo, S. Nagamori, M. Tsubuki, and K. Moriishi. Antiviral Research, 2021. 194: 105165. PMID[34419484].
[PubMed]. HBV_10_2021.
2. Effect of Entecavir and Atorvastatin in a Duck Model of Hepatitis B Combined with Nonalcoholic Fatty Liver Disease. Zhang, S.A., Y.D. Cai, H.C. Wu, Z.X. Wu, and D.L. Li. Acta Medica Mediterranea, 2021. 37(5): p. 2323-2327. ISI[000702178700005].
[WOS]. HBV_10_2021.
Patent Citations
3. Compositions and Methods of Inhibition of Transcription and Replication of HBV. Chen, J., Y.K. Law, K.W. Wong, and A.L. Huang. Patent. 2021. 2021-104919 2021104919.
[Patent]. HBV_10_2021.